The Vitamin B12 market in the USA recorded a modest improvement during late June 2026, as Vitamin B12 CFR Los Angeles prices increased by 0.29% in the week ending June 26 after remaining stable through most of the month. Despite the weekly gain, the market continued to operate within a broader 12-week bearish trend, although prices were still 1.51% higher month-on-month, indicating limited upward momentum. Demand for Vitamin B12 remained consistent across pharmaceutical, nutraceutical, dietary supplement, and animal nutrition sectors. Buyers largely followed routine procurement schedules, while speculative purchasing remained absent, contributing to stable market activity. On the supply side, Vitamin B12 production, inventories, and logistics remained uninterrupted, ensuring comfortable product availability and preventing major price volatility. Looking ahead, the Vitamin B12 market is expected to remain balanced as steady downstream demand and sufficient inventories continue to support stable pricing. However, the ongoing bearish trend is likely to limit stronger price gains. Future Vitamin B12 price direction will depend on pharmaceutical demand, inventory replenishment, and any unexpected supply chain disruptions affecting global trade.
The Vitamin B12 market in the USA recorded a slight improvement in late June 2026, with Vitamin B12 CFR Los Angeles prices edging up by 0.29% during the week ending June 26. According to ChemAnalyst, the weekly increase followed stable pricing through early and mid-June, indicating a calm trading environment. Although the market remains within a broader 12-week bearish trend, Vitamin B12 prices were still 1.51% higher on a month-on-month basis, reflecting limited upward momentum supported by balanced fundamentals.
Demand for Vitamin B12 remained stable across key downstream industries throughout June. Pharmaceutical manufacturers continued regular procurement for injectable formulations and fortified medicines, while nutraceutical and dietary supplement producers-maintained routine purchasing to meet consistent consumer demand. The animal nutrition sector also sustained healthy consumption of Vitamin B12, supporting steady offtake without triggering aggressive spot buying. Market participants largely focused on scheduled replenishment rather than speculative inventory accumulation, resulting in balanced trading activity.
Supply conditions for Vitamin B12 remained comfortable during the month. Production facilities operated normally, inventories were sufficient, and logistics across the CFR Los Angeles trade route experienced no significant disruptions. Stable freight movement and uninterrupted product availability ensured consistent deliveries. In addition, upstream manufacturing costs remained largely unchanged, as feedstock and energy prices showed little volatility. These favourable supply conditions prevented any major fluctuations in Vitamin B12 prices despite the modest late-month increase.
Weekly price movements further highlighted the stable nature of the Vitamin B12 market. Prices remained unchanged during the first half of June before posting the 0.29% increase in the final week. The improvement represented only a minor correction within the ongoing 12-week bearish cycle rather than a significant trend reversal. Market sentiment remained cautious, with buyers continuing to procure according to immediate production requirements instead of building excess inventories. As a result, Vitamin B12 trading volumes remained steady throughout the month.
Looking ahead, the outlook for the Vitamin B12 market remains cautiously balanced. While the 1.51% monthly gain and the late-June price increase indicate mild upward support, the prevailing bearish trend is expected to limit stronger price recovery. Future Vitamin B12 price movements will largely depend on pharmaceutical and dietary supplement demand, inventory replenishment cycles, and any unexpected disruptions in global supply chains. Unless these market fundamentals change significantly, Vitamin B12 prices are expected to remain range-bound during the coming weeks, with only modest fluctuations anticipated.
